152 related articles for article (PubMed ID: 16715951)
1. Evaluation of the relationship between physiological FDG uptake in the heart and age, blood glucose level, fasting period, and hospitalization.
Kaneta T; Hakamatsuka T; Takanami K; Yamada T; Takase K; Sato A; Higano S; Kinomura S; Fukuda H; Takahashi S; Yamada S
Ann Nucl Med; 2006 Apr; 20(3):203-8. PubMed ID: 16715951
[TBL] [Abstract][Full Text] [Related]
2. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
[TBL] [Abstract][Full Text] [Related]
3. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.
de Groot M; Meeuwis AP; Kok PJ; Corstens FH; Oyen WJ
Eur J Nucl Med Mol Imaging; 2005 Jan; 32(1):98-101. PubMed ID: 15605289
[TBL] [Abstract][Full Text] [Related]
4. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D-glucose.
Ding HJ; Shiau YC; Wang JJ; Ho ST; Kao A
Nucl Med Commun; 2002 Oct; 23(10):961-5. PubMed ID: 12352594
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of myocardial 18F-fluorodeoxyglucose positron emission computed tomography in dilated cardiomyopathy and ischemic cardiomyopathy.
Yamaguchi H; Hasegawa S; Yoshioka J; Uehara T; Hashimoto K; Kusuoka H; Kuzuya T; Hori M; Nishimura T
Ann Nucl Med; 2000 Feb; 14(1):33-8. PubMed ID: 10770578
[TBL] [Abstract][Full Text] [Related]
6. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
Okumura W; Iwasaki T; Toyama T; Iso T; Arai M; Oriuchi N; Endo K; Yokoyama T; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Dec; 45(12):1989-98. PubMed ID: 15585472
[TBL] [Abstract][Full Text] [Related]
8. Comparison of myocardial F-18 FDG uptake between overnight and non-overnight fasting in non-diabetic healthy subjects.
Lee HY; Nam HY; Shin SK
Jpn J Radiol; 2015 Jul; 33(7):385-91. PubMed ID: 25981760
[TBL] [Abstract][Full Text] [Related]
9. Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: assessment by F-18-FDG PET study.
Uehara T; Ishida Y; Hayashida K; Shimonagata T; Miyake Y; Sago M; Oka H; Nagata S; Miyatake K; Nishimura T
Ann Nucl Med; 1998 Apr; 12(2):95-103. PubMed ID: 9637280
[TBL] [Abstract][Full Text] [Related]
10. Associations of physiologic myocardial
Kang JY; Lee MY; Kim YH
Ann Nucl Med; 2021 Feb; 35(2):195-202. PubMed ID: 33387280
[TBL] [Abstract][Full Text] [Related]
11. Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.
Manabe O; Kroenke M; Aikawa T; Murayama A; Naya M; Masuda A; Oyama-Manabe N; Hirata K; Watanabe S; Shiga T; Katoh C; Tamaki N
J Nucl Cardiol; 2019 Jun; 26(3):909-918. PubMed ID: 29243072
[TBL] [Abstract][Full Text] [Related]
12. Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake.
Harisankar CN; Mittal BR; Agrawal KL; Abrar ML; Bhattacharya A
J Nucl Cardiol; 2011 Oct; 18(5):926-36. PubMed ID: 21732228
[TBL] [Abstract][Full Text] [Related]
13. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based
Hu L; Qiu C; Wang X; Xu M; Shao X; Wang Y
BMC Cardiovasc Disord; 2018 Oct; 18(1):203. PubMed ID: 30373519
[TBL] [Abstract][Full Text] [Related]
14. Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.
Minamimoto R
Jpn J Radiol; 2021 Jun; 39(6):540-557. PubMed ID: 33517516
[TBL] [Abstract][Full Text] [Related]
15. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
Shao D; Tian XW; Gao Q; Liang CH; Wang SX
Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
[TBL] [Abstract][Full Text] [Related]
16. Myocardial FDG-PET examination during fasting and glucose loading states by means of a one-day protocol.
Tsuchida T; Sadato N; Yonekura Y; Sugimoto K; Nakano A; Lee JD; Takahashi N; Waki A; Ishii Y; Itoh H
Ann Nucl Med; 2001 Oct; 15(5):433-8. PubMed ID: 11758948
[TBL] [Abstract][Full Text] [Related]
17. High intraindividual variability of global myocardial 18F-FDG uptake over time.
Zöphel K; Kotzerke J
J Nucl Med; 2008 Sep; 49(9):1570; author reply 1570-1. PubMed ID: 18703615
[No Abstract] [Full Text] [Related]
18. Suppression of myocardial 18F-FDG uptake with a preparatory "Atkins-style" low-carbohydrate diet.
Coulden R; Chung P; Sonnex E; Ibrahim Q; Maguire C; Abele J
Eur Radiol; 2012 Oct; 22(10):2221-8. PubMed ID: 22592807
[TBL] [Abstract][Full Text] [Related]
19. Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
Kobayashi Y; Kumita S; Fukushima Y; Ishihara K; Suda M; Sakurai M
J Cardiol; 2013 Nov; 62(5):314-9. PubMed ID: 23810066
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of augmented fluorine-18 deoxyglucose uptake in remote normoperfused myocardium in patients with acute coronary syndrome under fasting conditions.
Nakano A; Lee JD; Shimizu H; Yonekura Y; Ueda T
J Nucl Cardiol; 2000; 7(5):454-60. PubMed ID: 11083194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
